Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eun-Mi Yu

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|December 25, 2014
Granulocytic sarcoma in a patient with chronic myeloid leukaemia in complete haematological, cytogenetic and molecular remissionAdam Kittai, Eun-Mi Yu, Imad Tabbara
Expert Opinion on Pharmacotherapy|February 2, 2022
Advances with androgen deprivation therapy for prostate cancerEun-Mi Yu, Jeanny B Aragon-Ching
Anticancer Research|September 27, 2015
Chronic Lymphocytic Leukemia: Current ConceptsEun-Mi Yu, Adam Kittai, Imad A Tabbara
Discovery Medicine|December 30, 2010
Angiogenesis inhibitors in prostate cancer therapyEun-mi Yu, Maneesh Jain, Jeanny B Aragon-Ching
Exploration of Targeted Anti-Tumor Therapy|September 16, 2024
The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC)Minira Aslanova, Eun-Mi Yu, Jeanny B Aragon-Ching
Cancer Biology & Therapy|June 25, 2010
The use of 5-alpha reductase inhibitors for the prevention of prostate cancerEun-mi Yu, Walid El-Ayass, Jeanny B Aragon-Ching
Research and Reports in Urology|December 5, 2023
Mechanistic Insights on Localized to Metastatic Prostate Cancer Transition and Therapeutic OpportunitiesEun-Mi Yu, Min Woo Hwang, Jeanny B Aragon-Ching
Cancer Treatment and Research Communications|November 28, 2022
Non-urothelial and urothelial variants of bladder cancerEun-Mi Yu, Sarah Belay, Wenping Li, et al.
Vaccines|August 28, 2021
A Contemporary Review of Immune Checkpoint Inhibitors in Advanced Clear Cell Renal Cell CarcinomaEun-Mi Yu, Laura Linville, Matthew Rosenthal, et al.
Therapeutic Advances in Urology|March 9, 2023
The role of switch maintenance therapy in urothelial cancersEun-Mi Yu, Mythri Mudireddy, Rakesh Biswas, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|December 25, 2014
Granulocytic sarcoma in a patient with chronic myeloid leukaemia in complete haematological, cytogenetic and molecular remissionAdam Kittai, Eun-Mi Yu, Imad Tabbara
Expert Opinion on Pharmacotherapy|February 2, 2022
Advances with androgen deprivation therapy for prostate cancerEun-Mi Yu, Jeanny B Aragon-Ching
Anticancer Research|September 27, 2015
Chronic Lymphocytic Leukemia: Current ConceptsEun-Mi Yu, Adam Kittai, Imad A Tabbara
Discovery Medicine|December 30, 2010
Angiogenesis inhibitors in prostate cancer therapyEun-mi Yu, Maneesh Jain, Jeanny B Aragon-Ching
Exploration of Targeted Anti-Tumor Therapy|September 16, 2024
The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC)Minira Aslanova, Eun-Mi Yu, Jeanny B Aragon-Ching
Cancer Biology & Therapy|June 25, 2010
The use of 5-alpha reductase inhibitors for the prevention of prostate cancerEun-mi Yu, Walid El-Ayass, Jeanny B Aragon-Ching
Research and Reports in Urology|December 5, 2023
Mechanistic Insights on Localized to Metastatic Prostate Cancer Transition and Therapeutic OpportunitiesEun-Mi Yu, Min Woo Hwang, Jeanny B Aragon-Ching
Cancer Treatment and Research Communications|November 28, 2022
Non-urothelial and urothelial variants of bladder cancerEun-Mi Yu, Sarah Belay, Wenping Li, et al.
Vaccines|August 28, 2021
A Contemporary Review of Immune Checkpoint Inhibitors in Advanced Clear Cell Renal Cell CarcinomaEun-Mi Yu, Laura Linville, Matthew Rosenthal, et al.
Therapeutic Advances in Urology|March 9, 2023
The role of switch maintenance therapy in urothelial cancersEun-Mi Yu, Mythri Mudireddy, Rakesh Biswas, et al.
Pageof 2